Clinical trial
Effect of Indacaterol on Inspiratory Capacity and Lung Function in Patients With…
NCT00422552 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00422552 |
|---|---|
| Title | Effect of Indacaterol on Inspiratory Capacity and Lung Function in Patients With COPD Versus Placebo and Formoterol |
| Official title | An Exploratory, Double-Blind Comparison of Inspiratory Capacity (IC) and FEV1 in COPD Patients Following Single Dose Administration of Indacaterol and Placebo and Open Label b.i.d. Administration of Formoterol |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | COPD |
| Intervention type | Drug |
| Interventions | Indacaterol (QAB149) |
| Enrollment | 30 |
| Start date | Sep 1, 2006 |
| First posted | Jan 17, 2007 |
| Last update posted | Jun 22, 2007 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: